Uploaded July 2026 | Updated September 2026, 3 weeks ago

---

Access to experimental therapies should focus on safety, oversight, and prevention rather than waiting until someone is terminally ill says Dylan Livingston. The conversation challenges the idea that innovation and patient protection are at odds, showing how better policy could help bring promising longevity therapies into a more regulated, evidence-based setting.

Full Episode on YouTube, Spotify and Apple Podcast. Link in the comment.

#LongevityTechnologyUnlocked #LongevityPodcast #RightToTry #DylanLivingston #PreventiveMedicine #HealthPolicy #Longevity #Healthspan